Extracellular vesicle-mediated effects (EV-mediated effects)

Extracellular vesicle-mediated effects refer to the therapeutic and biological outcomes achieved through extracellular vesicles, which are nano-sized, lipid bilayer-enclosed particles secreted by virtually all cell types. These membrane-bound structures range from 20-30 nanometers to 10 microns in diameter and serve as natural carriers of diverse cellular cargo including proteins, lipids, and nucleic acids. EVs function as bioactive mediators of intercellular communication and have emerged as promising therapeutic agents in regenerative medicine and drug delivery. Rather than being a traditional molecular target like a receptor or enzyme, EV-mediated effects represent a therapeutic platform where the vesicles themselves act as delivery vehicles or biological modulators. MSC-derived EVs have demonstrated particular promise in treating cardiovascular diseases, neurological disorders, musculoskeletal conditions, and organ injuries through mechanisms including tissue regeneration, immune modulation, anti-inflammatory actions, and promotion of cell proliferation and differentiation. The therapeutic potential can be enhanced through molecular engineering to load specific cargo or display targeting ligands on the EV surface for directed delivery to specific tissues or cell types.

Other names

Extracellular vesicle effectsEV-mediated therapeutic effectsEV-based therapeutic mechanismsExosome-mediated effects

Transfer of bioactive cargo (proteins, lipids, nucleic acids) to recipient cells, Modulation of immune responses (shifting M1 to M2 macrophage phenotype), Promotion of cell proliferation and differentiation, Anti-inflammatory effects through cytokine modulation, Tissue repair and regeneration, Neuroprotection, Angiogenesis promotion, Targeting specific cells through surface receptor-ligand interactions